126 related articles for article (PubMed ID: 8590922)
21. Determination of indinavir in plasma by solid-phase extraction and column liquid chromatography.
Poirier JM; Robidou P; Jaillon P
Ther Drug Monit; 1999 Aug; 21(4):404-10. PubMed ID: 10442693
[TBL] [Abstract][Full Text] [Related]
22. Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction.
Colombo S; Guignard N; Marzolini C; Telenti A; Biollaz J; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(1):25-34. PubMed ID: 15358304
[TBL] [Abstract][Full Text] [Related]
23. Determination of an in vivo metabolite of a human immunodeficiency virus protease-inhibitor in human plasma by high-performance liquid chromatography with tandem mass spectrometry.
Woolf E; Haddix HM; Matuszewski B
J Chromatogr A; 1997 Feb; 762(1-2):311-9. PubMed ID: 9098990
[TBL] [Abstract][Full Text] [Related]
24. Quantitative determination of CGP 61755, a protease inhibitor, in plasma and urine by high-performance liquid chromatography and fluorescence detection.
Flesch G; Mann C; Degen PH
J Chromatogr B Biomed Sci Appl; 1997 Aug; 696(1):123-30. PubMed ID: 9300916
[TBL] [Abstract][Full Text] [Related]
25. High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications.
Choi SO; Rezk NL; Kashuba AD
J Pharm Biomed Anal; 2007 Mar; 43(4):1562-7. PubMed ID: 17236737
[TBL] [Abstract][Full Text] [Related]
26. A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method.
D'Avolio A; Sciandra M; Siccardi M; Baietto L; de Requena DG; Bonora S; Di Perri G
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):374-8. PubMed ID: 17092784
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection.
van Heeswijk RP; Hoetelmans RM; Harms R; Meenhorst PL; Mulder JW; Lange JM; Beijnen JH
J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):159-68. PubMed ID: 9869376
[TBL] [Abstract][Full Text] [Related]
28. High-performance liquid chromatographic method for the simultaneous determination of HIV-1 protease inhibitors indinavir, saquinavir and ritonavir in plasma of patients during highly active antiretroviral therapy.
Langmann P; Klinker H; Schirmer D; Zilly M; Bienert A; Richter E
J Chromatogr B Biomed Sci Appl; 1999 Nov; 735(1):41-50. PubMed ID: 10630889
[TBL] [Abstract][Full Text] [Related]
29. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
30. High performance liquid chromatographic method for the determination of HIV-1 protease inhibitor tipranavir in plasma of patients during highly active antiretroviral therapy.
Langmann P; Heinz W; Klinker H; Schirmer D; Guhl C; Leyh M; Winzer R
Eur J Med Res; 2008 Feb; 13(2):52-8. PubMed ID: 18424362
[TBL] [Abstract][Full Text] [Related]
31. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA
Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513
[TBL] [Abstract][Full Text] [Related]
32. ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.
Kempf DJ; Marsh KC; Denissen JF; McDonald E; Vasavanonda S; Flentge CA; Green BE; Fino L; Park CH; Kong XP
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2484-8. PubMed ID: 7708670
[TBL] [Abstract][Full Text] [Related]
33. Determination of saquinavir in human plasma by high-performance liquid chromatography.
Ha HR; Follath F; Bloemhard Y; Krähenbühl S
J Chromatogr B Biomed Sci Appl; 1997 Jul; 694(2):427-33. PubMed ID: 9252059
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography.
Hugen PW; Verweij-van Wissen CP; Burger DM; Wuis EW; Koopmans PP; Hekster YA
J Chromatogr B Biomed Sci Appl; 1999 Apr; 727(1-2):139-49. PubMed ID: 10360433
[TBL] [Abstract][Full Text] [Related]
35. Determination of a novel cognitive enhancer, X9121, and its mono N-oxide metabolite, XG696, in dog plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection.
Kapil RP; Lee W; Padovani PK; Wong NY; Holm KA; Lam GN
J Chromatogr B Biomed Appl; 1995 Mar; 665(1):226-31. PubMed ID: 7795797
[TBL] [Abstract][Full Text] [Related]
36. Sensitive and rapid method for the simultaneous quantification of the HIV-protease inhibitors indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by reversed-phase liquid chromatography.
Bouley M; Briere C; Padoin C; Petitjean O; Tod M
Ther Drug Monit; 2001 Feb; 23(1):56-60. PubMed ID: 11206045
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics, metabolism and pharmacodynamics of a benzimidazole angiotensin II type 1 receptor antagonist in the beagle dog and cynomologus monkey.
Kakiki M; Ishihara H
Xenobiotica; 1998 Jan; 28(1):77-91. PubMed ID: 9493321
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous determination of YM928, a novel noncompetitive AMPA receptor antagonist, and its demethylated metabolite in rat, dog and monkey plasma by high-performance liquid chromatography with ultraviolet detection.
Kato K; Noguchi K; Aoki T; Soeishi Y; Kamimura H
Biomed Chromatogr; 2006 Dec; 20(12):1328-35. PubMed ID: 16977590
[TBL] [Abstract][Full Text] [Related]
39. Determination of BMS-186318 in dog, rat and monkey plasma by liquid chromatography-ionspray mass spectrometry.
Jemal M; Hawthorne D
J Pharm Biomed Anal; 1995 Dec; 14(1-2):43-8. PubMed ID: 8833965
[TBL] [Abstract][Full Text] [Related]
40. [Simultaneous quantitative determination of amprenavir and indinavir in human plasma by high-performance liquid chromatography].
Laussine S; Roux A; Delhotal-Landes B; Flouvat B
Ann Biol Clin (Paris); 2001; 59(2):169-75. PubMed ID: 11282520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
